Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-05

Clinical Trial Update: Study of Hypofractionated Radiotherapy Alone in Locally Advanced Nonsmall Cell Lung Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating hypofractionated radiotherapy alone in locally advanced non-small cell lung cancer was terminated; results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III | Phase 2 | Status: TERMINATED | Results posted: 2022-10-05